MX2010003368A - Derivados de imidazol. - Google Patents
Derivados de imidazol.Info
- Publication number
- MX2010003368A MX2010003368A MX2010003368A MX2010003368A MX2010003368A MX 2010003368 A MX2010003368 A MX 2010003368A MX 2010003368 A MX2010003368 A MX 2010003368A MX 2010003368 A MX2010003368 A MX 2010003368A MX 2010003368 A MX2010003368 A MX 2010003368A
- Authority
- MX
- Mexico
- Prior art keywords
- imidazole derivatives
- sup
- compounds
- tumors
- formula
- Prior art date
Links
- 150000002460 imidazoles Chemical class 0.000 title 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
- C07D233/92—Nitro radicals attached in position 4 or 5
- C07D233/94—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102007047738A DE102007047738A1 (de) | 2007-10-05 | 2007-10-05 | Imidazolderivate |
| PCT/EP2008/007367 WO2009046804A1 (de) | 2007-10-05 | 2008-09-09 | Imidazolderivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010003368A true MX2010003368A (es) | 2010-04-30 |
Family
ID=40151186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010003368A MX2010003368A (es) | 2007-10-05 | 2008-09-09 | Derivados de imidazol. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20100249132A1 (OSRAM) |
| EP (1) | EP2193122B1 (OSRAM) |
| JP (2) | JP5725860B2 (OSRAM) |
| KR (1) | KR20100075602A (OSRAM) |
| CN (1) | CN101809001B (OSRAM) |
| AR (1) | AR068659A1 (OSRAM) |
| AU (1) | AU2008310117B2 (OSRAM) |
| BR (1) | BRPI0817609A2 (OSRAM) |
| CA (1) | CA2701568C (OSRAM) |
| DE (1) | DE102007047738A1 (OSRAM) |
| EA (1) | EA201000558A1 (OSRAM) |
| ES (1) | ES2601139T3 (OSRAM) |
| IL (1) | IL204683A (OSRAM) |
| MX (1) | MX2010003368A (OSRAM) |
| WO (1) | WO2009046804A1 (OSRAM) |
| ZA (1) | ZA201003125B (OSRAM) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102009049211A1 (de) * | 2009-10-13 | 2011-04-28 | Merck Patent Gmbh | Sulfoxide |
| WO2012106343A2 (en) | 2011-02-01 | 2012-08-09 | The Board Of Trustees Of The University Of Illinois | Hdac inhibitors and therapeutic methods using the same |
| ES2587856T3 (es) | 2011-03-18 | 2016-10-27 | Ono Pharmaceutical Co., Ltd. | Derivado de tetrahidrocarbolina |
| ES2748656T3 (es) * | 2011-10-28 | 2020-03-17 | Inhibitaxin Ltd | Derivados de piridazina útiles en terapia |
| US9409895B2 (en) | 2012-12-19 | 2016-08-09 | Novartis Ag | Autotaxin inhibitors |
| BR112015014372A8 (pt) | 2012-12-19 | 2019-10-29 | Novartis Ag | inibidores de autotaxina, seus usos, e composição e combinação farmacêuticas". |
| KR20160033726A (ko) | 2013-07-18 | 2016-03-28 | 노파르티스 아게 | 헤테로방향족 고리-벤질-아미드-사이클 코어를 포함하는 오토탁신 억제제 |
| EP3022201A1 (en) * | 2013-07-18 | 2016-05-25 | Novartis AG | Autotaxin inhibitors |
| HRP20210957T1 (hr) | 2013-11-22 | 2021-09-17 | Sabre Therapeutics Llc | Spojevi inhibitori autotaksina |
| US9051320B1 (en) | 2014-08-18 | 2015-06-09 | Pharmakea, Inc. | Methods for the treatment of metabolic disorders by a selective small molecule autotaxin inhibitor |
| EP3194374B1 (en) * | 2014-09-15 | 2018-08-01 | Idorsia Pharmaceuticals Ltd | Triazole compounds as t-type calcium channel blockers |
| GB201501870D0 (en) | 2015-02-04 | 2015-03-18 | Cancer Rec Tech Ltd | Autotaxin inhibitors |
| GB201502020D0 (en) | 2015-02-06 | 2015-03-25 | Cancer Rec Tech Ltd | Autotaxin inhibitory compounds |
| EP4026549A1 (en) | 2015-05-27 | 2022-07-13 | Sabre Therapeutics LLC | Autotaxin inhibitors and uses thereof |
| WO2016197009A1 (en) | 2015-06-05 | 2016-12-08 | Vertex Pharmaceuticals Incorporated | Triazoles for the treatment of demyelinating diseases |
| WO2018106641A1 (en) | 2016-12-06 | 2018-06-14 | Vertex Pharmaceuticals Incorporated | Pyrazoles for the treatment of demyelinating diseases |
| WO2018106646A1 (en) | 2016-12-06 | 2018-06-14 | Vertex Pharmaceuticals Incorporated | Aminotriazoles for the treatment of demyelinating diseases |
| WO2018106643A1 (en) | 2016-12-06 | 2018-06-14 | Vertex Pharmaceuticals Incorporated | Heterocyclic azoles for the treatment of demyelinating diseases |
| US20230277490A1 (en) * | 2020-07-31 | 2023-09-07 | Cedars-Sinai Medical Center | Glutamine as an anticancer therapy in solid tumors |
| EP4197596A1 (en) | 2021-12-15 | 2023-06-21 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Imidazole derivatives for the treatment and prophylaxis of infectious diseases |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5747469A (en) | 1991-03-06 | 1998-05-05 | Board Of Regents, The University Of Texas System | Methods and compositions comprising DNA damaging agents and p53 |
| GB9904387D0 (en) | 1999-02-25 | 1999-04-21 | Pharmacia & Upjohn Spa | Antitumour synergistic composition |
| AU4972900A (en) | 1999-04-08 | 2000-11-14 | Arch Development Corporation | Use of anti-vegf antibody to enhance radiation in cancer therapy |
| DE19954707A1 (de) * | 1999-11-13 | 2001-05-17 | Merck Patent Gmbh | Imidazolverbindungen als Phosphodiesterase VII-Hemmer |
| TWI288136B (en) * | 2000-02-18 | 2007-10-11 | Kirin Brewery | Novel isoxazole and thiazole compounds and use thereof as drugs |
| FR2889190A1 (fr) * | 2005-08-01 | 2007-02-02 | Merck Sante Soc Par Actions Si | Nouveaux derives d'imidazoles carboxamides comme inhibiteurs de fructose -1,6-biphosphatase et compositions pharmaceutiques les contenant |
-
2007
- 2007-10-05 DE DE102007047738A patent/DE102007047738A1/de not_active Withdrawn
-
2008
- 2008-09-09 JP JP2010527344A patent/JP5725860B2/ja not_active Expired - Fee Related
- 2008-09-09 US US12/681,380 patent/US20100249132A1/en not_active Abandoned
- 2008-09-09 EA EA201000558A patent/EA201000558A1/ru unknown
- 2008-09-09 KR KR1020107009777A patent/KR20100075602A/ko not_active Withdrawn
- 2008-09-09 WO PCT/EP2008/007367 patent/WO2009046804A1/de not_active Ceased
- 2008-09-09 ES ES08801940.1T patent/ES2601139T3/es active Active
- 2008-09-09 AU AU2008310117A patent/AU2008310117B2/en not_active Ceased
- 2008-09-09 BR BRPI0817609 patent/BRPI0817609A2/pt not_active IP Right Cessation
- 2008-09-09 CA CA2701568A patent/CA2701568C/en not_active Expired - Fee Related
- 2008-09-09 EP EP08801940.1A patent/EP2193122B1/de not_active Not-in-force
- 2008-09-09 MX MX2010003368A patent/MX2010003368A/es not_active Application Discontinuation
- 2008-09-09 CN CN2008801089528A patent/CN101809001B/zh not_active Expired - Fee Related
- 2008-10-03 AR ARP080104330A patent/AR068659A1/es unknown
-
2010
- 2010-03-23 IL IL204683A patent/IL204683A/en not_active IP Right Cessation
- 2010-05-04 ZA ZA2010/03125A patent/ZA201003125B/en unknown
-
2015
- 2015-01-05 JP JP2015000566A patent/JP5997782B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE102007047738A1 (de) | 2009-04-09 |
| JP2015096544A (ja) | 2015-05-21 |
| CA2701568A1 (en) | 2009-04-16 |
| CN101809001A (zh) | 2010-08-18 |
| WO2009046804A1 (de) | 2009-04-16 |
| US20100249132A1 (en) | 2010-09-30 |
| JP5725860B2 (ja) | 2015-05-27 |
| AR068659A1 (es) | 2009-11-25 |
| ZA201003125B (en) | 2011-05-25 |
| AU2008310117B2 (en) | 2013-07-18 |
| EP2193122A1 (de) | 2010-06-09 |
| JP2010540576A (ja) | 2010-12-24 |
| EP2193122B1 (de) | 2016-08-03 |
| BRPI0817609A2 (pt) | 2015-03-31 |
| JP5997782B2 (ja) | 2016-09-28 |
| CA2701568C (en) | 2017-06-06 |
| AU2008310117A1 (en) | 2009-04-16 |
| KR20100075602A (ko) | 2010-07-02 |
| EA201000558A1 (ru) | 2010-10-29 |
| IL204683A0 (en) | 2010-11-30 |
| ES2601139T3 (es) | 2017-02-14 |
| CN101809001B (zh) | 2012-12-12 |
| IL204683A (en) | 2014-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010003368A (es) | Derivados de imidazol. | |
| MX2010003366A (es) | Derivados de piperidina y piperazina para el tratamiento de tumores. | |
| MX2010003365A (es) | Derivados de tiazol para el tratamiento de cancer. | |
| MX2009013077A (es) | Derivados dde benzoxazolona. | |
| MX2009008798A (es) | Derivados de iminipiridina y sus usos como microbicidas. | |
| UA100540C2 (en) | 2-benzylpyridazinone derivatives as met kinase inhibitors | |
| WO2010000364A8 (de) | Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate | |
| MX2009012708A (es) | Derivados de piridazinona. | |
| UA100007C2 (ru) | Гетероциклические ингибиторы мек, их применение и фармацевтическая композиция, которая их содержит | |
| MY163477A (en) | Pyrimidinyl-pyridazinone derivatives | |
| TN2011000279A1 (en) | Novel pyrazole -4-n-alkoxycarboxamides as microbiocides | |
| MX2010003612A (es) | Derivados de oxadiazol. | |
| MX361467B (es) | Compuestos de isoindolina para uso en el tratamiento de cancer. | |
| EA201100880A1 (ru) | Бензонафтиридиновые соединения в качестве ингибиторов аутотаксина | |
| PH12012501905A1 (en) | Quinoline derivatives and their use as fungicides | |
| TN2009000509A1 (en) | Pyrazole carboxylic acid amides useful as microbiocides | |
| MX2009013341A (es) | Derivados de 6-(pirrolopiridinil)-pirimidinil-2-amina. | |
| MX2010007392A (es) | Antagonistas de trpa1. | |
| MX2009012709A (es) | Derivados de arileter-piridazinona. | |
| MX2010007391A (es) | Antagonistas de trpa1. | |
| MX2010004017A (es) | 5-cianotienopiridinas para el tratamiento de tumores. | |
| MX2011007165A (es) | Derivados de piridazinona. | |
| MY152061A (en) | Pyrrolopyrimidinecarboxamides | |
| MX2008002104A (es) | Derivados de 1-acildihidropirazol. | |
| GEP20125603B (en) | Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |